MedBen Rx
  • About Us
  • Genomic Testing
  • Resources
    • MedBen Rx Blog
    • Online Services & Forms
  • Contact Us
  • MedBen Access
  • MedBen.com
Select Page

Get Total Transparency in Pharmacy Management

Jul 12, 2021 | MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Transparency

Lack of disclosure is a common theme for many pharmacy benefit managers (PBMs), be it with employers or state governments. From Benefits Pro: “At least a half-dozen states and the District of Columbia are investigating pharmacy benefit managers, The Wall Street...

MedBen Rx Clients are Saving More. Why?

Jun 1, 2021 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings, Transparency

MedBen Rx clients save 21.6% when switching from traditional PBMs. What accounts for such a substantial difference? With MedBen Rx you pay what the pharmacy pays – we use the drug’s acquisition cost as a baseline to reduce your costs. MedBen Rx offers total...

Don’t “Rein In” PBMs… Cut Them Out with MedBen Rx

Dec 10, 2020 | MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Transparency

A Columbus Dispatch article outlines the struggles Ohio Medicaid has experienced in trying to “rein in the middlemen in the prescription drug supply chain” – pharmacy benefit managers. Their year-long effort to replace outsider PBMs with a state-run PBM has met with...

MedBen Saving Solutions Counter Affordability Concerns

Oct 16, 2020 | MedBen Rx, Prescription drugs, Rx Spending, Savings, Transparency

A National Alliance of Healthcare Purchaser Coalitions survey asked employers what they thought were the greatest threats to coverage affordability. Their responses… and how MedBen counters these concerns with proven saving solutions: Drug prices are a threat to...

“Wasteful Drugs” Cost Employers $6 Billion Annually

Sep 18, 2020 | MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Rx Costs, Rx Spending, Savings, Transparency

Employers could save billion of dollars every year by avoiding “wasteful drugs,” according to BenefitsPro. Guidelines from Pacific Business Group on Health and and researchers from Johns Hopkins University identified 49 high-price medications with less costly...

The MedBen Rx Advocate Model: Pass-through Transparency, No Margin Manipulation

May 28, 2020 | MedBen Rx, MedBen Rx Advocate, Pharmacy Benefits Manager (PBM), Rx Costs, Savings, Transparency

A recent Benefits Pro article highlights two pharmacy benefits management (PBM) business models: traditional and pass-through. MedBen Rx Advocate begins with the pass-through approach but takes it one step further by eliminating margin manipulation. The traditional...
« Older Entries
Next Entries »

Categories

  • 340B
  • Access solution
  • Access solutions
  • Acquisition Cost Index (ACI)
  • Affordable Care Act
  • Anniversaries
  • Announcements
  • Appropriateness Solutions
  • Avande
  • Average Wholesale Price
  • Benefits Advisory Conference
  • Benefits preservation
  • Biologics
  • Biosimilar
  • Brand Name Drugs
  • Brian Fargus
  • Cancer
  • Caroline Fraker
  • Case Study
  • Cholesterol
  • Chronic conditions
  • Claims
  • Client Report
  • Comparative Effectiveness
  • Compliance
  • Consolidated Appropriations Act of 2021 (CAA)
  • Cost Plus
  • Cost Plus Pricing
  • Cost projections
  • Cost Savings
  • Diabetes
  • Discounts
  • Doug Freeman
  • Drug costs
  • Drug makers
  • Drug marketing
  • Drug reimportation
  • Evidence-based research
  • Federal Trade Commission (FTC)
  • Food and Drug Administration (FDA)
  • Formularies
  • Fraud
  • Gene therapy
  • Generic Drugs
  • Genetic testing
  • Genomics
  • GLP-1s
  • Government
  • Guarantees
  • Health and Human Services
  • Health systems
  • Heart medications
  • High-value formulary
  • History
  • Humalog
  • Humira
  • Idacio
  • Inflation
  • Kurt Harden
  • Lawsuits
  • Legislation
  • Lifestyle
  • Limited Use HRA
  • Lobbying
  • Luke Burchard
  • MDMA (ecstasy)
  • MedBen
  • MedBen Access
  • MedBen Basics
  • MedBen Board of Directors\
  • MedBen employees
  • MedBen Rx
  • MedBen Rx Advocate
  • MedBen Rx Alliance
  • MedBen Rx News
  • MedBen University
  • Medicare
  • Mental health
  • Mobile app
  • Mounjaro
  • News
  • Nutrigenomics
  • Obesity
  • Online Services
  • Opinions
  • Outcomes
  • Overprescribing
  • Own Use
  • Ozempic
  • Patient advocacy program
  • Perigon Pharmacy 360
  • Pharmacies
  • Pharmacogenomics
  • Pharmacy Benefits Manager (PBM)
  • Pharmacy Services Administrator (PSA)
  • Precision medicine
  • Prescription drugs
  • Prescription Portal
  • Pricing solutions
  • Psychedelic drugs
  • Rebates
  • Regulatory
  • Reporting
  • Research
  • Rx Advertising
  • Rx Costs
  • Rx Facts
  • Rx prices
  • Rx Spending
  • RxDC report
  • Savings
  • Specialty Drugs
  • Spread Pricing
  • State legislation
  • Statins
  • Stelara
  • Study
  • Surveys
  • Transparency
  • Trend
  • TruDataRx
  • Trulicity
  • Value
  • Ventegra
  • Wegovy
  • Weight loss
  • Weight loss drugs
  • Weight management
  • Wellness
  • White paper
  • Zepbound
  • About Us
  • Contact Us
  • Blog
  • Online Services
  • MedBen Access
  • Sitemap
  • Privacy
  • MedBen.com

Sign Up for our Newsletter

  • This field is for validation purposes and should be left unchanged.
© 2025 MedBen Rx. All rights reserved.